Lack of association of CCR2-64I and CCR5-Δ32 with type 1 diabetes and latent autoimmune diabetes in adults

被引:12
作者
Gambelunghe, G
Ghaderi, M
Brozzetti, A
Del Sindaco, P
Gharizadeh, B
Nyren, P
Hjelmström, P
Nikitina-Zake, L
Sanjeevi, CB
Falorni, A
机构
[1] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[2] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy
[3] Royal Inst Technol, Dept Biotechnol, Stockholm Ctr Phys Astron & Biotechnol, Stockholm, Sweden
[4] Univ Orebro, Div Biomed, Inst Healthcare Sci, S-70130 Orebro, Sweden
关键词
chemokine; CCR2-641; gene; CCR5-Delta; 32; type; 1; diabetes; latent autoimmune diabetes of the adult;
D O I
10.1016/S0198-8859(03)00064-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is well known that type I diabetes mellitus (T1DM) is a complex genetic disease resulting from the autoimmune destruction of pancreatic beta cells. Several genes have been associated with susceptibility and/or protection for T1DM, but the disease risk is mostly influenced by genes located in the class II region of the major histocompatibility complex. The attraction of leukocytes to tissues is essential for inflammation and the beginning of autoimmune reaction. The process is controlled by chemokines, which are chemotactic cytolines. Some studies have shown that CCR2-64I and CCR5-Delta32 might be important for protection of susceptibility to some immunologically-mediated disorders. In the present study, we demonstrate the lack of association between CCR2-64I and CCR5-Delta32 gene polymorphism and TIDM and we desrcibe a new method for a simple and more precise genotyping of the CCR2 gene. (C) American Society for Histocompatibility and Immunogenetics, 2003. Published by Elsevier Inc.
引用
收藏
页码:629 / 632
页数:4
相关论文
共 19 条
[1]   The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection [J].
Abdi, R ;
Smith, RN ;
Makhlouf, L ;
Najafian, N ;
Luster, AD ;
Auchincloss, H ;
Sayegh, MH .
DIABETES, 2002, 51 (08) :2489-2495
[2]  
[Anonymous], 1995, ANN HUM GENET
[3]   A GENOME-WIDE SEARCH FOR HUMAN TYPE-1 DIABETES SUSCEPTIBILITY GENES [J].
DAVIES, JL ;
KAWAGUCHI, Y ;
BENNETT, ST ;
COPEMAN, JB ;
CORDELL, HJ ;
PRITCHARD, LE ;
REED, PW ;
GOUGH, SCL ;
JENKINS, SC ;
PALMER, SM ;
BALFOUR, KM ;
ROWE, BR ;
FARRALL, M ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE, 1994, 371 (6493) :130-136
[4]   Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus [J].
Falorni, A ;
Gambelunghe, G ;
Forini, F ;
Kassi, G ;
Cosentino, A ;
Candeloro, P ;
Bolli, GB ;
Brunetti, P ;
Calcinaro, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :309-316
[5]   Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes [J].
Gambelunghe, G ;
Ghaderi, M ;
Cosentino, A ;
Falorni, A ;
Brunetti, P ;
Falorni, A ;
Sanjeevi, CB .
DIABETOLOGIA, 2000, 43 (04) :507-514
[6]  
HARRIS M, 1979, DIABETES, V28, P1039
[7]   The role of the C-C chemokine receptor 2 gene polymorphism V641 (CCR2-641) in sarcoidosis in a Japanese population [J].
Hizawa, N ;
Yamaguchi, E ;
Furuya, K ;
Jinushi, E ;
Ito, A ;
Kawakami, Y .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) :2021-2023
[8]   The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].
Huang, YX ;
Paxton, WA ;
Wolinsky, SM ;
Neumann, AU ;
Zhang, LQ ;
He, T ;
Kang, S ;
Ceradini, D ;
Jin, ZQ ;
Yazdanbakhsh, K ;
Kunstman, K ;
Erickson, D ;
Dragon, E ;
Landau, NR ;
Phair, J ;
Ho, DD ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (11) :1240-1243
[9]  
LERNMARK A, 1997, TXB DIABETES
[10]   Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes [J].
Lohmann, T ;
Laue, S ;
Nietzschmann, U ;
Kapellen, TM ;
Lehmann, I ;
Schroeder, S ;
Paschke, R ;
Kiess, W .
DIABETES, 2002, 51 (08) :2474-2480